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A 47-year-old woman with end-stage renal disease due to
hypertensive nephropathy, anuric, receiving intermittent
hemodialysis for 4 years presented with an itching and
burning sensation on sun-exposed sites on her distal limbs
and face. This itching and burning was associated with
hyperpigmentation of the skin. She reported the sudden
onset of multiple bullaes and skin fragility, especially on
forearms and dorsal portions of hands (Figure 1a,b). There
was no history of use of photosensitizing drugs, and
gadolinium, or alcohol abuse. The results of serum tests for
human immunodeficiency virus, human T lymphotropic
virus, hepatitis C virus, and hepatitis B virus were negative.
Porphyrin assays showed normal plasma and fecal levels.
Biopsy of lesional skin revealed subepidermal blisters,
lymphocytic perivascular infiltrate, and sclerosis of collagen.
Direct immunofluorescence was positive showing linear
immunoglobulin G deposits in vessel walls and at the
basement membrane zone. These results were consistent with
a diagnosis of hemodialysis-associated pseudoporphyria, and
oral treatment with N-acetylcysteine 1200mg/day was
initiated and maintained during 1 year. The skin lesions
resolved after 2 months of therapy; however, scarring
and sclerodermoids were observed, especially on the fingers
(Figure 1c).
Pseudoporphyria is a photodistributed vesicobullous
disorder with clinical and histologic features similar to those
of porphyria cutanea tarda but without accompanying bio-
chemical porphyrin abnormalities. In the case of suspected
pseudoporphyria, a careful medical history, including the
amount of ultraviolet light exposure, medications taken, and
family history, should be obtained. Physical examination
should include an observation of the presence or absence
of hyperpigmentation, vesicobullous skin lesions, hyper-
trichosis, sclerodermoid features, dystrophic calcification,
facial scarring, waxy thickening, milia, and skin fragility.
Chronic renal failure and dialysis have been implicated in its
etiology, but further investigation is necessary to elucidate the
pathophysiology fully. Proposed factors include diuretics,
aluminum hydroxide, polyvinyl chloride dialysis tubing,
hemosiderosis, silicone particles, erythropoietin, and suscepti-
bility to oxygen-free radicals. Treatment includes adminis-
tration of the glutathione precursor, N-acetylcysteine, the
discontinuation of contact with suspected agents, and the use
of sun protection, especially against UVA wavelengths.
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Figure 1 |Pseudoporphyria. (a) Hyperpigmentation of the skin. (b) Bullae and crusts secondary to
scratch lesions. (c) Scarring and sclerodermoid appearance after treatment with N-acetylcysteine.
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